Ultragenyx Pharmaceutical Inc. (RARE) › Shares OutstandingUltragenyx Pharmaceutical Inc. (RARE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 3.77M2014: 31.93M2015: 38.88M2016: 41.24M2017: 44.17M2018: 50.86M2019: 57.84M2020: 66.82M2021: 69.34M2022: 70.20M2023: 82.32M2024: 92.50M2025: 96.60M96.60M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202596.60M+4.4%202492.50M+12.4%202382.32M+17.3%202270.20M+1.2%202169.34M+3.8%202066.82M+15.5%201957.84M+13.7%201850.86M+15.2%201744.17M+7.1%201641.24M+6.1%201538.88M+21.8%201431.93M+747.9%20133.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share